P. Reichardt

发表

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P Reichardt, I Judson, Robin L. Jones, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.

J. Blay, J. Verweij, I. Judson, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Schlemmer, P. Casali, P. Reichardt, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.

B. Dörken, P. Reichardt, R. Bargou, 1997, Blood.

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

J. Blay, M. van Glabbeke, J. Verweij, 2008, European journal of cancer.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, E. Álava, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?

C. Mussi, P. Hohenberger, P. Casali, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}.

P. Schlattmann, P. Reichardt, R. Hofheinz, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, E. Álava, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts

P. Reichardt, F. Rothmann, M. Grothoff, 2011, British Journal of Cancer.

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib.

H. Joensuu, S. Leyvraz, H. Gelderblom, 2009, European journal of cancer.

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

J. Blay, M. van Glabbeke, G. Demetri, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)

M. Beckmann, T. Vogl, P. Reichardt, 2015, Geburtshilfe und Frauenheilkunde.

The treatment of uterine sarcomas.

P. Reichardt, Peter Reichardt, P. Reichardt, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

INVICTUS: A phase III, interventional, double-blind, placebo-controlled study to assess the safety and efficacy of ripretinib as ≥ 4th-line therapy in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior anticancer therapies (NCT03353753)

M. Heinrich, S. George, J. Zalcberg, 2019, Annals of Oncology.

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’

J. Blay, L. Collette, R. Sciot, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.

G. Steger, P. Reichardt, G. Fountzilas, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

C. Boni, E. Van Cutsem, J. Tabernero, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Hypertension as a potential biomarker of efficacy in patients with gastrointestinal stromal tumor treated with sunitinib.

G. Demetri, S. George, D. Cohen, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Schlemmer, P. Casali, P. Reichardt, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapies.

E. Wardelmann, P. Hohenberger, P. Reichardt, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant therapy in primary GIST: state-of-the-art.

J. Blay, J. Verweij, A. Cesne, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Robin L. Jones, S. Sleijfer, J. Blay, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS)

S. Bielack, C. Blattmann, L. Kager, 2023, Cancers.

Indication and results of surgery following imatinib treatment of locally advanced or metastatic GI stromal tumors (GIST).

E. Wardelmann, P. Hohenberger, C. Langer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I/II trial of the oral mTOR-inhibitor everolimus (E) and imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM: Study update

J. Blay, J. Fletcher, G. Demetri, 2005 .

Results of the phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR inhibitor ridaforolimus (R) as maintenance therapy in advanced sarcoma patients (pts) following clinical benefit from prior standard cytotoxic chemotherapy (CT).

J. Blay, G. Demetri, A. Cesne, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.

A. Schindler, W. Jonat, F. Jänicke, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.

P Reichardt, J. Blay, G. Demetri, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

P Reichardt, R Gürtler, D. Huhn, 1996, Cancer research.

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

J. Verweij, M. Glabbeke, M. Schlemmer, 2008, European journal of cancer.

Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review

O. Riesterer, R. Issels, S. Corradini, 2023, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Computed tomographic criteria for the discrimination of subcentimeter lung nodules in patients with soft-tissue sarcomas.

D. Schnapauff, M. Pech, J. Ricke, 2011, Clinical imaging.

Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO‐B.O.S.S.)

K. S. Hall, S. Bielack, M. Eriksson, 2023, Cancer.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib.

H. Joensuu, S. Leyvraz, H. Gelderblom, 2009, European journal of cancer.

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

M. Burgess, R. Riedel, M. Gounder, 2023, The New England journal of medicine.

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’

J. Blay, S. Aamdal, R. Sciot, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.